4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-030277
Chief Commercial Officer sold 1,417 shares at an average $87.80 ($124,413)
- Chief Commercial Officer acquired 100 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +100 | $16.14 | $1,614 | 26,602 | D |
| 2024-03-08 | Sale : show line 2 in the form 10b5-1 | −100 | $90.04 | $9,004 | 26,502 | D |
| 2024-03-08 | Sale : show line 3 in the form 10b5-1 | −1,317 | $87.63 | $115,409 | 25,185 | D |
| Open-market sales · 1,417 sh · avg $87.80 · $124,413 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-08 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −100 | 15,646 | D |
Loading xslF345X05/ownership.xml…